H. Dohner, D. J. Weisdorf, and C. D. Bloomfield, Acute myeloid leukemia, N Engl J Med, vol.373, issue.12, pp.1136-1152, 2015.

C. Rollig and G. Ehninger, How I treat hyperleukocytosis in acute myeloid leukemia, Blood, vol.125, issue.21, pp.3246-3252, 2015.

H. Inaba and C. H. Pui, Glucocorticoid use in acute lymphoblastic leukaemia, Lancet Oncol, vol.11, issue.11, pp.1096-1106, 2010.

C. Kelaidi, S. Chevret, D. Botton, and S. , Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience, J Clin Oncol, vol.27, issue.16, pp.2668-2676, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00484579

M. A. Sanz and P. Montesinos, How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia, Blood, vol.123, issue.18, pp.2777-2782, 2014.

A. Stucki, A. S. Rivier, M. Gikic, N. Monai, M. Schapira et al., Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination, Blood, vol.97, issue.7, pp.2121-2129, 2001.

J. D. Griffin, A. Rambaldi, E. Vellenga, D. C. Young, D. Ostapovicz et al., Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors, Blood, vol.70, issue.4, pp.1218-1221, 1987.

U. Baschant and J. Tuckermann, The role of the glucocorticoid receptor in inflammation and immunity, J Steroid Biochem Mol Biol, vol.120, issue.2-3, pp.69-75, 2010.

D. Grimwade, R. K. Hills, and A. V. Moorman, Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials, Blood, vol.116, issue.3, pp.354-365, 2010.

S. Bertoli, E. Berard, and F. Huguet, Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia, Blood, vol.121, issue.14, pp.2618-2626, 2013.

A. Pigneux, J. L. Harousseau, and F. Witz, Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS, J Clin Oncol, vol.28, issue.18, pp.3028-3034, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00849638

H. Dohner, E. H. Estey, and S. Amadori, Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, vol.115, issue.3, pp.453-474, 2010.

A. Chabrol, L. Cuzin, and F. Huguet, Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia, Haematologica, vol.95, issue.6, pp.996-1003, 2010.

B. D. Cheson, J. M. Bennett, and K. J. Kopecky, Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia, J Clin Oncol, vol.21, issue.24, pp.4642-4649, 2003.

E. Griessinger, F. Anjos-afonso, and J. Vargaftig, Frequency and dynamics of leukemia-Initiating cells during short-term ex vivo culture informs outcomes in acute myeloid leukemia patients, Cancer Res, vol.76, issue.8, pp.2082-2086, 2016.

E. Griessinger, F. Anjos-afonso, and I. Pizzitola, A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms, Stem Cells Transl Med, vol.3, issue.4, pp.520-529, 2014.

M. Kurata, S. K. Rathe, and N. J. Bailey, Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML, Sci Rep, vol.6, p.36199, 2016.

D. Malani, A. Murumagi, and B. Yadav, Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML, Leukemia, vol.31, issue.5, pp.1187-1195, 2017.

T. Farge, E. Saland, and F. De-toni, Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism, Cancer Discov, vol.7, issue.7, pp.716-735, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02465205

H. Hackl, K. Steinleitner, and K. Lind, A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes, Leuk Lymphoma, vol.56, issue.4, pp.1126-1128, 2015.

L. Simon, V. P. Lavallee, and M. E. Bordeleau, Chemogenomic landscape of RUNX1-mutated AML reveals importance of RUNX1 allele dosage in genetics and glucocorticoid sensitivity, Clin Cancer Res, vol.23, issue.22, pp.6969-6981, 2017.

H. Miyoshi, M. Ohki, T. Nakagawa, and Y. Honma, Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with a t(8;21) chromosome translocation, Leuk Res, vol.21, issue.1, pp.45-50, 1997.

R. G. Verhaak, B. J. Wouters, and C. A. Erpelinck, Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling, Haematologica, vol.94, issue.1, pp.131-134, 2009.

, Cancer Genome Atlas Research N. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, N Engl J Med, vol.368, issue.22, pp.2059-2074, 2013.

G. Hicsonmez, The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis, Leuk Res, vol.30, issue.1, pp.60-68, 2006.

E. M. Pietras, Inflammation: a key regulator of hematopoietic stem cell fate in health and disease, Blood, vol.130, issue.15, pp.1693-1698, 2017.

J. M. Rosen and C. T. Jordan, The increasing complexity of the cancer stem cell paradigm, Science, vol.324, issue.5935, pp.1670-1673, 2009.

A. Volk, J. Li, and J. Xin, Co-inhibition of NF-kappaB and JNK is synergistic in TNFexpressing human AML, J Exp Med, vol.211, issue.6, pp.1093-1108, 2014.

K. Schepers, T. B. Campbell, and E. Passegue, Normal and leukemic stem cell niches: insights and therapeutic opportunities, Cell Stem Cell, vol.16, issue.3, pp.254-267, 2015.

C. Korn and S. Mendez-ferrer, Myeloid malignancies and the microenvironment, Blood, vol.129, issue.7, pp.811-822, 2017.

S. Oberoi, T. Lehrnbecher, and B. Phillips, Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis, Leuk Res, vol.38, issue.4, pp.460-468, 2014.